title: Homocysteine and cardiovascular risk: the perils of reductionism in a complex system.
authors.affiliation: Section for Pharmacology, Institute of Medicine, University of Bergen, Bergen, Norway. per.ueland@ikb.uib.no
authors.forename: Per Magne
authors.initials: PM
authors.lastname: Ueland
authors.forename: Joseph
authors.initials: J
authors.lastname: Loscalzo
mesh_terms: D000818:Animals; D003327:Coronary Disease / Q000097:blood* / Q000209:etiology / Q000517:prevention & control; D019587:Dietary Supplements; D005492:Folic Acid / Q000008:administration & dosage; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000517:prevention & control; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D011110:Polymorphism, Genetic; D012306:Risk; D014803:Vitamin B Complex / Q000008:administration & dosage
chemical_list: D006710:Homocysteine; D014803:Vitamin B Complex; D005492:Folic Acid; C573423:MTHFR protein, human; D042965:Methylenetetrahydrofolate Reductase (NADPH2)